Education
About Us
Working with TipRanks
Follow Us
Sanofi (SNYNF)
:SNYNF
Earnings Data
Report Date
Oct 24, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
3.29Last Year’s EPS
3.31Same Quarter Last Year
Moderate Buy
Based on 14 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
Sanofi reported strong sales growth driven by Immunology and new product launches, with Dupixent continuing its success. The vaccine business also showed robust growth. However, challenges such as expected declines in flu vaccine sales, mixed results for itepekimab, and increased operational expenses present concerns. Strategic acquisitions and sustainability leadership are positive indicators, but potential impacts from U.S. tariffs remain uncertain.Company Guidance -
Q3 2025
Strong Sales Growth
Net sales increased by 10.1% at constant exchange rate in Q2 2025, driven by Immunology, pharma launches, and Beyfortus.
Dupixent Success
Dupixent sales reached EUR 3.8 billion, up 21% in Q2, driven by strong demand and improved indications across geographies.
Successful Launches
New product launches generated close to EUR 1 billion in sales, now representing 10% of total sales.
Vaccine Business Growth
Vaccine sales increased by 10.3% in Q2 2025, driven by Beyfortus expansion and late flu season effects.
Strategic Acquisitions
Completion of Blueprint Medicines acquisition strengthens Sanofi's position in rare immunology diseases.
Sustainability Leadership
Sanofi ranked as the world's 10th most sustainable company across all industries and #1 in pharma and biotech.
SNYNF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SNYNF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 31, 2025 | $98.07 | $92.60 | -5.58% |
Apr 24, 2025 | $101.92 | $102.43 | +0.50% |
Jan 30, 2025 | $100.30 | $103.41 | +3.10% |
Oct 25, 2024 | $98.00 | $102.87 | +4.97% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sanofi (SNYNF) report earnings?
Sanofi (SNYNF) is schdueled to report earning on Oct 24, 2025, Before Open (Confirmed).
What is Sanofi (SNYNF) earnings time?
Sanofi (SNYNF) earnings time is at Oct 24, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SNYNF EPS forecast?
SNYNF EPS forecast for the fiscal quarter 2025 (Q3) is 3.29.